Paper36906275
Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome.
Hines MR and 30 others. Transplant Cell Ther, 2023. Cited by 338 papers, by iCite.
Cite this record
ConductScience Library. Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome. Papers, record 36906275. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36906275
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Intramural
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lymphohistiocytosis, Hemophagocytic | Major topic |
| Neurotoxicity Syndromes | Major topic |
| Adult | |
| Humans | |
| United States | |
| Child | |
| T-Lymphocytes | |
| Immunotherapy, Adoptive | |
| Cytokine Release Syndrome |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA008748 | NCI NIH HHS | United States | P30CA008748 | PubMed and NIH | NIH RePORTER |
| P50 CA186781 | NCI NIH HHS | United States | P50CA186781 | PubMed | NIH RePORTER |
| ZIA BC011823 | Intramural NIH HHS | United States | ZIABC011823 | PubMed and NIH | NIH RePORTER |
Trials3
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT06072989 | Repeat Intravenous Infusions of B4T2-001 CAR-T Without Lymphodepleting Chemotherapy for Solid Tumors | Background | ClinicalTrials.gov | |
| NCT06703216 | Pre-emptive Anakinra for Cytokine Event Reduction | Background | ClinicalTrials.gov | |
| NCT06879340 | Evaluating the Safety and Efficacy of DuoCAR20.19.22-D95 in Adult Patients With Relapsed or Refractory B-cell Malignancies | Background | ClinicalTrials.gov |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 41067707 | Erratum to 'Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome'[Transplant Cell Ther. 2023 Jul;29(7):438.e1-438.e16. Epub 2023 Mar 9]. | https://conductscience.org/library/papers/41067707 |
Source PubMed
References140
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30965140 | Efficacy, Toxicity, and Infectious Complications in Ruxolitinib-Treated Patients with Corticosteroid-Refractory Graft-versus-Host Disease after Hematopoietic Cell Transplantation. | Biol Blood Marrow Transplant | 2019 | https://conductscience.org/library/papers/30965140 | PubMed |
| 2 | 30753567 | CAR T-Cell Associated Neurotoxicity: Mechanisms, Clinicopathologic Correlates, and Future Directions. | J Natl Cancer Inst | 2019 | https://conductscience.org/library/papers/30753567 | PubMed |
| 3 | 35708727 | HLH treatment: smarter, not harder. | Blood | 2022 | https://conductscience.org/library/papers/35708727 | PubMed |
| 4 | 29434334 | Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'. | Nat Rev Clin Oncol | 2018 | https://conductscience.org/library/papers/29434334 | PubMed |
| 5 | 29385370 | Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia. | N Engl J Med | 2018 | https://conductscience.org/library/papers/29385370 | PubMed |
| 6 | 35986653 | Allogeneic CD34-selected stem cell boost as salvage treatment of life-threatening infection and severe cytopenias after CAR-T cell therapy. | Transfusion | 2022 | https://conductscience.org/library/papers/35986653 | PubMed |
| 7 | 36316312 | Effect of granulocyte colony-stimulating factor on toxicities after CAR T cell therapy for lymphoma and myeloma. | Blood Cancer J | 2022 | https://conductscience.org/library/papers/36316312 | PubMed |
| 8 | 32374962 | Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32374962 | PubMed |
| 9 | 36131317 | Limited efficacy of tocilizumab in adult patients with secondary hemophagocytic lymphohistiocytosis: a retrospective cohort study. | Orphanet J Rare Dis | 2022 | https://conductscience.org/library/papers/36131317 | PubMed |
| 10 | 24876563 | Current concepts in the diagnosis and management of cytokine release syndrome. | Blood | 2014 | https://conductscience.org/library/papers/24876563 | PubMed |
| 11 | 35266965 | Use of Early Intrathecal Therapy to Manage High-Grade Immune Effector Cell-Associated Neurotoxicity Syndrome. | JAMA Oncol | 2022 | https://conductscience.org/library/papers/35266965 | PubMed |
| 12 | 31515353 | Ruxolitinib for refractory/relapsed hemophagocytic lymphohistiocytosis. | Haematologica | 2020 | https://conductscience.org/library/papers/31515353 | PubMed |
| 13 | 34114322 | Continuous intravenous anakinra for treating severe secondary haemophagocytic lymphohistiocytosis/macrophage activation syndrome in critically ill children. | Pediatr Blood Cancer | 2021 | https://conductscience.org/library/papers/34114322 | PubMed |
| 14 | 27632680 | Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia. | Crit Care Med | 2017 | https://conductscience.org/library/papers/27632680 | PubMed |
| 15 | 23778995 | Recombinant human thrombopoietin is an effective treatment for thrombocytopenia in hemophagocytic lymphohistiocytosis. | Ann Hematol | 2013 | https://conductscience.org/library/papers/23778995 | PubMed |
| 16 | 33496754 | Practical guidelines for monitoring and management of coagulopathy following tisagenlecleucel CAR T-cell therapy. | Blood Adv | 2021 | https://conductscience.org/library/papers/33496754 | PubMed |
| 17 | 24553386 | Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia. | Sci Transl Med | 2014 | https://conductscience.org/library/papers/24553386 | PubMed |
| 18 | 21830940 | Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. | N Engl J Med | 2011 | https://conductscience.org/library/papers/21830940 | PubMed |
| 19 | 31912207 | Transfusion strategies in non-bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine. | Intensive Care Med | 2020 | https://conductscience.org/library/papers/31912207 | PubMed |
| 20 | 34309174 | Consequences of hemophagocytic lymphohistiocytosis-like cytokine release syndrome toxicities and concurrent bacteremia. | Pediatr Blood Cancer | 2021 | https://conductscience.org/library/papers/34309174 | PubMed |
Cited by238
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 338 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42964569 | Artificial intelligence-enabled nursing surveillance for pediatric cancer immunotherapy: integrating biomarkers, patient-reported outcomes, and long-term toxicity management. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42964569 | PubMed |
| 42939519 | Emapalumab in IFN-γ-Driven Hyperinflammatory Disorders: Mechanisms, Clinical Evidence, and Emerging Therapeutic Applications. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42939519 | PubMed |
| 42936537 | Chimeric antigen receptor-engineered cell therapy for asthma: advances in targeting type 2 inflammation and translational challenges. | Front Immunol | 2026 | https://conductscience.org/library/papers/42936537 | PubMed |
| 42935367 | An Australian Narrative Review of Adoptive Cellular Therapies in Malignancy: Expanding Indications, Referral Pathways and Safety Beyond Specialist Centres. | Med J Aust | 2026 | https://conductscience.org/library/papers/42935367 | PubMed |
| 42921052 | When, Where, and How Much: Toward Smarter Design and Delivery of CAR T‑Cell Therapy. | ACS Bio Med Chem Au | 2026 | https://conductscience.org/library/papers/42921052 | PubMed |
| 42890994 | Chimeric Antigen Receptor T-cell (CAR-T) Therapy in Autoimmune Diseases: A Narrative Review. | Cureus | 2026 | https://conductscience.org/library/papers/42890994 | PubMed |
| 42890889 | Immune-effector and infection-associated reporting patterns of CD20×CD3 bispecific antibodies in B-cell lymphoma: a label-anchored FAERS analysis with descriptive JADER contextualization. | Front Immunol | 2026 | https://conductscience.org/library/papers/42890889 | PubMed |
| 42866565 | Precision Management of Tumor-Associated Fever: From Classification to Targeted Intervention. | Cancer Manag Res | 2026 | https://conductscience.org/library/papers/42866565 | PubMed |
| 42819351 | CAR T cell cancer immunotherapy: who does the job? | Front Immunol | 2026 | https://conductscience.org/library/papers/42819351 | PubMed |
| 42809697 | CAR-T Cell Therapy: Engineering Remission in Refractory Myeloma. | Cancer J | 2026 | https://conductscience.org/library/papers/42809697 | PubMed |
| 42807139 | Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis in the Gulf Cooperation Council: a modified Delphi approach. | Front Immunol | 2026 | https://conductscience.org/library/papers/42807139 | PubMed |
| 42769528 | The transformative potential of lipid nanoparticles tailored for acute myeloid leukemia immunotherapy. | Front Immunol | 2026 | https://conductscience.org/library/papers/42769528 | PubMed |
| 42767771 | Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia, version 2.0. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/42767771 | PubMed |
| 42739214 | Beyond the Storm: CXCL9 and the New Era of Precision Hemophagocytic Lymphohistiocytosis Diagnostics. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42739214 | PubMed |
| 42714733 | CRS and ICANS: Early detection and personalized management. | Blood Res | 2026 | https://conductscience.org/library/papers/42714733 | PubMed |
| 42706167 | [Mechanism and clinical progress of JAK inhibitors in hemophagocytic lymphohistiocytosis]. | Zhonghua Xue Ye Xue Za Zhi | 2026 | https://conductscience.org/library/papers/42706167 | PubMed |
| 42650392 | Infection-Related Adverse Events of Tisagenlecleucel in Pediatric Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia: A FAERS Pharmacovigilance Study. | Children (Basel) | 2026 | https://conductscience.org/library/papers/42650392 | PubMed |
| 42602092 | Anti-CD123 CAR-T therapy combined with autologous SCT and venetoclax maintenance in refractory BPDCN ineligible for allogeneic transplantation: a case report and review of the literature. | Front Immunol | 2026 | https://conductscience.org/library/papers/42602092 | PubMed |
| 42578568 | Predictive Models for Toxicities after CAR T-cell Therapy: Challenges and Opportunities. | Blood Cancer Discov | 2026 | https://conductscience.org/library/papers/42578568 | PubMed |
| 42489798 | Incorporating Immunotherapies into the Evolving Standard of Care for Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia. | Paediatr Drugs | 2026 | https://conductscience.org/library/papers/42489798 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36906275
GET https://conductscience.org/api/papers/v1/36906275/authors?page=2